PEspeaks

Apr 09, 2018
Pharmaceutical Executive
Pharma's evolving landscape in recent years has created the need to recruit experts from outside of industry—and establish new pathways for traditional executive roles in the life sciences.
Apr 09, 2018
Pharmaceutical Executive
Looking at the balance of optimism and caution discussed at eyeforpharma Barcelona around pharma’s embrace of AI.
Apr 07, 2018
Jin Zhang looks at how China's CART-T therapy race is heating up.
Apr 04, 2018
Leela Barham reviews the Institute for Clinical Effectiveness Review's announced pilot program, which allow manufacturers to scrutinize executable versions of draft cost-effectiveness models.
Apr 04, 2018
FDA is moving slowly in liberalizing off-label communications amid outrage over opioid promotion. Jill Wechsler reports.
Mar 31, 2018
In terms of important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs, writes Bagrat Lalayan.
Mar 21, 2018
Looking back at the agenda of a 1985 EFPIA conference, Reflector sees that, three decades on, the European drug industry is still seeking a pill for its own ills.
Mar 07, 2018
Pharmaceutical Executive
Tackling some of the unintended consequences associated with value-based contracting in pharma and efforts to advance toward sustainable outcomes-based engagement.
Mar 07, 2018
Pharmaceutical Executive
The public and policymakers seek more transparency in pricing and product development.
Feb 20, 2018
In the coming weeks, the EU will decide if the degree of protection offered to drug firms by research incentives such as the SPC are really in the interests of patients and society. Reflector reports.
native1_300x100
lorem ipsum